Cardiovascular Risk Reduction in Patients With Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists

1.00 CME
60 MINS
$0 FEE
SAVE
heart

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.


Support Statement

This activity is supported by an educational grant from Merck & Co., Inc.


Activity Description

Given the complex interplay between insulin resistance and cardiometabolic risk, patients with diabetes are up to 4 times more likely to die from cardiovascular (CV) disease. Optimal management of CV risk requires the integrated effort of multidisciplinary specialists, including cardiologists and endocrinologists, who are current on the latest guidelines and therapeutic strategies to reduce CV risk. In this CME activity, a multidisciplinary panel of experts will provide education on how to apply the latest clinical evidence regarding available and emerging agents to reduce the risk of major CV events in patients with diabetes.


Target Audience

The intended audience for this activity is cardiologists, endocrinologists, and other health care professionals involved in the management of patients with diabetes.


Learning Objective(s)

Upon successful completion of this activity, participants should be better able to:

  • Review the interplay between insulin resistance, inflammation, and atherosclerosis and how this contributes to CV risk. 
  • Assess the latest clinical evidence regarding available and emerging agents to reduce CV risk in patients with type 2 diabetes mellitus (T2DM).
  • Examine multidisciplinary strategies to individualize treatment for patients with T2DM based on the latest clinical evidence as well as patient characteristics and comorbidities.

Activity Chair

Donald A. Smith, MD, MPH 
Associate Professor of Medicine and Preventive Medicine
Director, Lipids and Metabolism
Zena and Michael A. Wiener Cardiovascular Institute
Marie-Josee and Henry R. Kravis Center for Cardiovascular Health
New York, NY


Faculty

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Executive Director of Interventional Cardiovascular Programs
Brigham and Women’s Hospital Heart and Vascular Center
Professor of Medicine
Harvard Medical School
Boston, MA

Peter P. Toth, MD, PhD, FAAFP, FICA, FAHA, FNLA, FASPC, FCCP, FACC
Director, Preventative Cardiology
CGH Medical Center
Sterling, IL
Professor, Clinical Family & Community Medicine
University of Illinois College of Medicine
Peoria, IL
Professor of Clinical Medicine
Michigan State University College of Osteopathic Medicine 
East Lansing, MI 
Adjunct Associate Professor Medicine 
Johns Hopkins University School of Medicine 
Baltimore, MD


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 31, 2019, to December 30, 2020.


How to Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Activity Chair and Faculty report the following relationship(s)

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Contracted Research: Abbott Medical Optics, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, CSL Behring, Eisai, Ethicon, Forest Laboratories, Idorsia, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, PhaseBio, Regeneron, Roche, Sanofi-Aventis, Synaptic, The Medicines Company

Donald A. Smith, MD, MPH
No relevant financial relationships to disclose.

Peter P. Toth, MD, PhD, FAAFP, FICA, FAHA, FNLA, FASPC, FCCP, FACC
Consulting Fees: Amarin, Amgen, Kowa, Resverlogix, Theravance
Speakers Bureau: Amarin, Amgen, Kowa, Novo Nordisk, Regeneron, Sanofi

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com